Literature DB >> 20139718

26S proteasome exhibits endoribonuclease activity controlled by extra-cellular stimuli.

Valentina A Kulichkova1, Anna S Tsimokha, Olga A Fedorova, Tatiana N Moiseeva, Andrew Bottril, Larissa Lezina, Larissa N Gauze, Irina M Konstantinova, Alexey G Mittenberg, Nickolai A Barlev.   

Abstract

26S proteasome is a large multi-subunit protein complex involved in proteolytic degradation of proteins. In addition to its canonical proteolytic activity, the proteasome is also associated with recently characterized endoribonuclease (endo- RNAse) activity. However, neither functional significance, nor the mechanisms of its regulation are currently known. In this report, we show that 26S proteasome is able to hydrolyze various cellular RNAs, including AU-rich mRNA of c-myc and c-fos. The endonucleolytic degradation of these mRNAs is exerted by one of the 26S proteasome subunits, PSMA5 (alpha5). The RNAse activity of 26S proteasome is differentially affected by various extra-cellular signals. Moreover, this activity contributes to the process of degradation of c-myc mRNA during induced differentiation of K562 cells, and may be controlled by phosphorylation of the adjacent subunits, PSMA1 (alpha6) and PSMA3 (alpha7). Collectively, the data presented in this report suggest a causal link between cell signalling pathways, endo-RNAse activity of the 26S proteasome complex and metabolism of cellular RNAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139718     DOI: 10.4161/cc.9.4.10829

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  19 in total

Review 1.  Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.

Authors:  Rafal Tomecki; Andrzej Dziembowski
Journal:  RNA       Date:  2010-07-30       Impact factor: 4.942

2.  Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.

Authors:  Alexey G Mittenberg; Tatyana N Moiseeva; Valeria O Kuzyk; Nickolai A Barlev
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

3.  Does proteasome regulate the level of microRNA-1 in cardiomyocytes? Application to anoxia-reoxygenation.

Authors:  Veronika Gurianova; Dmytro Stroy; Peter Kruzliak; Victoria Kyrichenko; Alex Moibenko; Victor Dosenko
Journal:  Mol Cell Biochem       Date:  2015-02-28       Impact factor: 3.396

4.  Simultaneous EGFP and tag labeling of the β7 subunit for live imaging and affinity purification of functional human proteasomes.

Authors:  Valentina A Kulichkova; Tatiana O Artamonova; Julia J Zaykova; Julia B Ermolaeva; Mikhail A Khodorkovskii; Nikolai A Barlev; Alexey N Tomilin; Anna S Tsimokha
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

5.  Prospective nested case-control study of feature genes related to leukemic evolution of myelodysplastic syndrome.

Authors:  Yan Ma; Bobin Chen; Xiaoping Xu; Guowei Lin
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

6.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

Review 7.  Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.

Authors:  Ivano Amelio; Vivien Landré; Richard A Knight; Andrey Lisitsa; Gerry Melino; Alexey V Antonov
Journal:  Oncotarget       Date:  2015

8.  miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.

Authors:  L Lezina; N Purmessur; A V Antonov; T Ivanova; E Karpova; K Krishan; M Ivan; V Aksenova; D Tentler; A V Garabadgiu; G Melino; N A Barlev
Journal:  Cell Death Dis       Date:  2013-12-12       Impact factor: 8.469

9.  DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.

Authors:  Tatiana N Moiseeva; Andrew Bottrill; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2013-09

10.  DNA damage modulates interactions between microRNAs and the 26S proteasome.

Authors:  Anna S Tsimokha; Valentina A Kulichkova; Elena V Karpova; Julia J Zaykova; Nikolai D Aksenov; Anastasia A Vasilishina; Andrei V Kropotov; Alexey Antonov; Nikolai A Barlev
Journal:  Oncotarget       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.